SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001361974-16-000026
Filing Date
2016-02-04
Accepted
2016-02-04 10:38:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 MERUS LABS SCHEDULE 13G DEC 2015 meruslabs13G_dec2015.txt SC 13G 15606
  Complete submission text file 0001361974-16-000026.txt   17487
Mailing Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1
Business Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1 416 593-3701
Merus Labs International Inc. (Subject) CIK: 0001031516 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-81986 | Film No.: 161387197
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20 EGLINTON AVENUE WEST SUITE 2000 TORONTO A6 M4R 1K8
Business Address 20 EGLINTON AVENUE WEST SUITE 2000 TORONTO A6 M4R 1K8 416-485-1010
Beutel, Goodman & Co Ltd. (Filed by) CIK: 0001361974 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G